About 9 results found for searched term "Platelet-activating Factor Receptor" (0.172 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M5855 | Rilapladib | Phospholipase |
| SB 659032 | ||
| Rilapladib (SB 659032) is a selective Lp-PLA2 (lipoprotein-associated phospholipase A2) inhibitor with an IC50 of 230 pM. Rilapladib (SB 659032) is also a PAFR (Platelet Activating Factor Receptor) antagonist. | ||
| M7100 | PAF (C16) | Others |
| C16-PAF | ||
| PAF (C16) is a platelet-activating factor and ligand for PAF G-protein-coupled receptor (PAFR). C16-PAF exhibits anti-apoptotic effect and inhibits caspase-dependent death by activating the PAFR. C16-PAF is a potent MAPK and MEK/ERK activator. C16-PAF induces increased vascular permeability. | ||
| M7486 | Apafant | Platelet-activating Factor Receptor |
| WEB 2086 | ||
| Apafant (WEB 2086) is a potent platelet-activating factor (PAF) antagonist, it inhibits PAF binding to human PAF receptors with a Ki of 9.9 nM. | ||
| M7615 | ABT-491 hydrochloride | Others |
| Highly potent, selective and orally active platelet-activating factor (PAF) receptor antagonist. | ||
| M8389 | SR 27417 | Others |
| SR 27417 is a long-acting, highly potent, specific competitive platelet-activating factor (PAF) receptor antagonist. | ||
| M9659 | Rac-Modipafant | Platelet-activating Factor Receptor |
| Modipafant racemate; UK-74505 | ||
| Rac-Modipafant (UK-74505) is an orally active, selective, long-acting irreversible platelet activating factor receptor (PAFR) antagonist. | ||
| M16525 | Pinusolide | Apoptosis |
| Pinusolide is a known platelet-activating factor (PAF) receptor binding antagonist. Pinusolide not only decreases the proliferation activity of tumor cells but specifically induces apoptosis. | ||
| M56307 | CP-96021 | Platelet-activating Factor Receptor |
| CP-96021 is a potent and orally available leukotriene D4 (LTD4 Ki=34 μM) / platelet activating factor (PAF Ki=37 μM) receptor antagonist. | ||
| M56230 | CP-96021 hydrochloride | Leukotriene Receptor |
| CP-96021 hydrochloride is a balanced, combined, potent and orally active leukotriene D4 (LTD4)/platelet activating factor (PAF) receptor antagonist with Ki values of 34 nM and 37 nM, respectively. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
